METASTATIC ENDOCRINE REFRACTORY

Clinical trials for METASTATIC ENDOCRINE REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new METASTATIC ENDOCRINE REFRACTORY trials appear

Sign up with your email to follow new studies for METASTATIC ENDOCRINE REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets stubborn breast cancer after hormone therapy fails

Disease control Recruiting now

This study is testing whether a drug called ivonescimab can help control a specific type of advanced breast cancer that has spread and no longer responds to standard hormone treatments. It will involve about 29 adults with metastatic invasive lobular carcinoma. The main goal is t…

Matched conditions: METASTATIC ENDOCRINE REFRACTORY

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

METASTATIC ENDOCRINE REFRACTORY

Get alerted when new METASTATIC ENDOCRINE REFRACTORY trials appear

New drug trial targets stubborn breast cancer after hormone therapy fails